Inventor
STAVENHAGEN JEFFREY B
US20 patents
⚠️ This page may combine multiple inventors who share the name “STAVENHAGEN JEFFREY B”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
H LUNDBECK AS
13 patentsUS10196439B2Feb 5, 2019
Antibodies specific for hyperphosphorylated tau and methods of use thereof
H LUNDBECK AS23 citations92
US11542323B2Jan 3, 2023
Agents, uses and methods for the treatment of synucleinopathy
H LUNDBECK AS6 citations85
US11524995B2Dec 13, 2022
Agents, uses and methods for the treatment of synucleinopathy
H LUNDBECK AS6 citations85
US10934348B2Mar 2, 2021
Antibodies specific for hyperphosphorylated tau and methods of use thereof
H LUNDBECK AS6 citations82
US10562962B2Feb 18, 2020
Antibodies specific for hyperphosphorylated tau and methods of use thereof
H LUNDBECK AS6 citations82
US10479835B2Nov 19, 2019
Agent, uses and methods for treatment
H LUNDBECK AS4 citations82
US10428147B2Oct 1, 2019
Anti-sortilin antibodies, uses and methods for treatment
H LUNDBECK AS4 citations82
US11739140B2Aug 29, 2023
Antibodies specific for hyperphosphorylated tau and methods of use thereof
H LUNDBECK AS1 citations71
US11548950B2Jan 10, 2023
Agent, uses and methods for treatment
H LUNDBECK AS1 citations71
US10889650B2Jan 12, 2021
Agent, uses and methods for treatment
H LUNDBECK AS2 citations71
US10894833B2Jan 19, 2021
Agents, uses and methods for treatment
H LUNDBECK AS2 citations70
US12421303B2Sep 23, 2025
Agents, uses and methods for the treatment of synucleinopathy
H LUNDBECK AS0 citations62
US12331123B2Jun 17, 2025
Agent, uses and methods for treatment
H LUNDBECK AS0 citations61
MACROGENICS INC
4 patentsUS8003774B2Aug 23, 2011
Identification and engineering of antibodies with variant Fc regions and methods of using same
MACROGENICS INC96 citations98
US10711069B2Jul 14, 2020
Methods for the treatment of disease using immunoglobulins having Fc regions with altered affinities for FcγRactivating and FcγRinhibiting
MACROGENICS INC7 citations84
US9708408B2Jul 18, 2017
Methods for the treatment of disease using immunoglobulins having Fc Regions with altered affinities for FcγRactivating and FcγRinhibiting
MACROGENICS INC9 citations84
US11787871B2Oct 17, 2023
Methods for the treatment of disease using immunoglobulins having fc regions with altered affinities for FcgammaRactivating and FegammaRinhibiting
MACROGENICS INC0 citations62
STAVENHAGEN JEFFREY B
2 patentsUS8652466B2Feb 18, 2014
Methods for the treatment of disease using immunoglobulins having Fc regions with altered affinities for FcγRactivating and FcγRinhibiting
STAVENHAGEN JEFFREY B50 citations96
US8192737B2Jun 5, 2012
Identification and engineering of antibodies with variant Fc regions and methods of using same
STAVENHAGEN JEFFREY B72 citations96